{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:10:13Z","timestamp":1792131013983,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1054\/jocn.2001.1027","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T17:52:37Z","timestamp":1027878757000},"page":"4-8","source":"Crossref","is-referenced-by-count":207,"title":["Neuroprotection and neurodegenerative disease"],"prefix":"10.1054","volume":"9","author":[{"given":"Frank J.E.","family":"Vajda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1054\/jocn.2001.1027_RF1","series-title":"Proc. 3rd Annual Topamax Symposium","article-title":"Basic research update: Evidence for neuroprotection with Topiramate","author":"White","year":"1999"},{"key":"10.1054\/jocn.2001.1027_RF2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/excr.1997.4026","article-title":"Apoptosis, excitotoxicity and neuropathology","volume":"239","author":"Leist","year":"1998","journal-title":"Exp Cell Res"},{"key":"10.1054\/jocn.2001.1027_RF3","first-page":"26.1, 33.11","article-title":"Neurodegenerative disorders","author":"Ellison","year":"2000"},{"key":"10.1054\/jocn.2001.1027_RF4","first-page":"31.1, 31.34","article-title":"Dementias","author":"Ellison","year":"2000"},{"key":"10.1054\/jocn.2001.1027_RF5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00004647-199906000-00001","article-title":"Excitotoxins in neuronal apoptosis and necrosis","volume":"19","author":"Nicotera","year":"1999","journal-title":"J Cerebral Blood Flow & Metab"},{"key":"10.1054\/jocn.2001.1027_RF6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0005-2728(98)00124-8","article-title":"Mitochondria, glutamate neurotoxicity and the death cascade","volume":"1366","author":"Montal","year":"1998","journal-title":"Biochim et Biophys Acta"},{"key":"10.1054\/jocn.2001.1027_RF7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0361-9230(98)00024-0","article-title":"Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis","volume":"46","author":"Martin","year":"1998","journal-title":"Brain Res Bull"},{"key":"10.1054\/jocn.2001.1027_RF8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00005072-196907000-00007","article-title":"Glutamate induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion","volume":"28","author":"Olney","year":"1969","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1054\/jocn.2001.1027_RF9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF01799116","article-title":"Neuropathology and pathogenesis of mitochondrial diseases","volume":"19","author":"Brown","year":"1996","journal-title":"J Inher Metab Dis"},{"key":"10.1054\/jocn.2001.1027_RF10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/biof.5520080107","article-title":"Neuroprotective versus neurodestructive effects of NO-related species","volume":"8","author":"Lipton","year":"1998","journal-title":"Biofactors"},{"key":"10.1054\/jocn.2001.1027_RF11","doi-asserted-by":"crossref","unstructured":"Ludolph, A, C, Meyer, T and Riepe, M, W. The role of excitotoxicityin ALS \u2013 what is the evidence?J Neurol 2000; 247(): I7\u2013I16.","DOI":"10.1007\/s004150050552"},{"key":"10.1054\/jocn.2001.1027_RF12","first-page":"33","article-title":"Glutamic acid and Alzheimer's disease","volume":"6","author":"Arias","year":"1998","journal-title":"Neurobiology"},{"key":"10.1054\/jocn.2001.1027_RF13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0959-4388(96)80100-0","article-title":"Mitochondria, free radicals and neurodegeneration","volume":"6","author":"Beal","year":"1996","journal-title":"Curr Opin Neurobiol"},{"key":"10.1054\/jocn.2001.1027_RF14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/biof.5520080317","article-title":"Neuronal excitotoxicity: the role of mitochondria","volume":"8","author":"Nichols","year":"1998","journal-title":"Biofactors"},{"key":"10.1054\/jocn.2001.1027_RF15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0165-0173(97)00056-8","article-title":"Role of mitochondrial Ca2+ regulation in neuronal and glial cell signalling","volume":"26","author":"Simpson","year":"1998","journal-title":"Brain Res Rev"},{"key":"10.1054\/jocn.2001.1027_RF16","first-page":"61","article-title":"Autosomal dominant nocturnal frontal lobe epilepsy","volume":"118","author":"Scheffer","year":"1995","journal-title":"A distinctive clinical disorder. Brain"},{"key":"10.1054\/jocn.2001.1027_RF17","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1528-1157.1999.tb00913.x","article-title":"Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs","volume":"40","author":"White","year":"1999","journal-title":"Epilepsia"},{"key":"10.1054\/jocn.2001.1027_RF18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/phrs.1997.0124","article-title":"A pharmacological and clinical review on Topiramate, a new antiepileptic drug","volume":"35","author":"Perucca","year":"1997","journal-title":"Pharmacol Res"},{"key":"10.1054\/jocn.2001.1027_RF19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0006-8993(98)00116-4","article-title":"Suppression by topiramate of epileptiform burst discharges in hippocampal CA3 neurons of spontaneously epileptic rat in vitro","volume":"789","author":"Hanaya","year":"1998","journal-title":"Brain Res"},{"key":"10.1054\/jocn.2001.1027_RF20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0006-8993(98)00410-7","article-title":"Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization","volume":"804","author":"Yang","year":"1998","journal-title":"Brain Res"},{"key":"10.1054\/jocn.2001.1027_RF21","first-page":"123","article-title":"Cellular actions of antiepileptic drugs","author":"Macdonald","year":"1999"},{"key":"10.1054\/jocn.2001.1027_RF22","first-page":"331","article-title":"Lamotrigine","author":"Walker","year":"1999"},{"key":"10.1054\/jocn.2001.1027_RF23","first-page":"5","article-title":"Pharmacology and mechanism of action of lamotrigine","author":"Meldrum","year":"1993"},{"key":"10.1054\/jocn.2001.1027_RF24","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/BF03160574","article-title":"Glutamate, excitotoxicity and amyotrophic lateral sclerosis","volume":"244","author":"Shaw","year":"1997","journal-title":"J Neurol"},{"key":"10.1054\/jocn.2001.1027_RF25","doi-asserted-by":"crossref","first-page":"I1","DOI":"10.1007\/s004150050551","article-title":"Oxidative stress in amyotrophic lateral sclerosis","volume":"247","author":"Robberecht","year":"2000","journal-title":"J Neurol"},{"key":"10.1054\/jocn.2001.1027_RF26","first-page":"27.1, 27.10","article-title":"Motor Neuron Disorders","author":"Ellison","year":"2000"},{"key":"10.1054\/jocn.2001.1027_RF27","first-page":"28.1, 28.16","article-title":"Parkinson's Disease","author":"Ellison","year":"2000"},{"key":"10.1054\/jocn.2001.1027_RF28","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1212\/WNL.47.6_Suppl_3.161S","article-title":"Oxidative stress and the pathogenesis of Parkinson's disease","volume":"47","author":"Jenner","year":"1996","journal-title":"Neurology"},{"key":"10.1054\/jocn.2001.1027_RF29","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1212\/WNL.47.6_Suppl_3.153S","article-title":"The aetiology of Parkinson's disease with emphasis on the MPTP story","volume":"47","author":"Langston","year":"1996","journal-title":"Neurology"},{"key":"10.1054\/jocn.2001.1027_RF30","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1212\/WNL.47.6_Suppl_3.137S","article-title":"Pharmacology of selegiline","volume":"47","author":"Gerlach","year":"1996","journal-title":"Neurology"},{"key":"10.1054\/jocn.2001.1027_RF31","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1212\/WNL.47.6_Suppl_3.171S","article-title":"Modulation of gene expression rather than monoamine oxidase inhibition: (\u2212)-deprenyl-related compounds in controlling neurodegeneration","volume":"47","author":"Tatton","year":"1996","journal-title":"Neurology"},{"key":"10.1054\/jocn.2001.1027_RF32","first-page":"287","article-title":"Brain neurotransmitters and neuropeptides in Parkinson's disease","volume":"34","author":"Rinne","year":"1984","journal-title":"Acta Physiol Pharmacol Latinoam"},{"key":"10.1054\/jocn.2001.1027_RF33","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1212\/WNL.47.6_Suppl_3.210S","article-title":"Selegiline: current perspectives on issues related to neuroprotection and mortality","volume":"47","author":"Olanow","year":"1996","journal-title":"Neurology"},{"key":"10.1054\/jocn.2001.1027_RF34","first-page":"A52","article-title":"Riluzole protects dopamine neurons against oxidative stress and impairment of cellular energy supply","volume":"54","author":"Burkhardt","year":"2000","journal-title":"Neurology"},{"key":"10.1054\/jocn.2001.1027_RF35","first-page":"19.1, 19.12","article-title":"Multiple Sclerosis","author":"Ellison","year":"2000"},{"key":"10.1054\/jocn.2001.1027_RF36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/135245859800400301","article-title":"Neuropathology in multiple sclerosis: new concepts","volume":"4","author":"Lassmann","year":"1998","journal-title":"Multiple Sclerosis"},{"key":"10.1054\/jocn.2001.1027_RF37","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1054\/jocn.2001.1027_RF38","first-page":"A59","article-title":"Intense immune ablative therapy with autologous hematopoietic stem cell rescue for progressive multiple sclerosis: a pilot safety study","volume":"54","author":"Cohen","year":"2000","journal-title":"Neurology"},{"key":"10.1054\/jocn.2001.1027_RF39","first-page":"A24","article-title":"An open label trial of combination MS therapy using IFN \u03b21a and oral methotrexate 20mg weekly","volume":"54","author":"Whartenby","year":"2000","journal-title":"Neurology"},{"key":"10.1054\/jocn.2001.1027_RF40","first-page":"31.1, 31.34","article-title":"Alzheimer's Disease","author":"Ellison","year":"2000"},{"key":"10.1054\/jocn.2001.1027_RF41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1750-3639.1996.tb00879.x","article-title":"Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischaemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species","volume":"6","author":"Lipton","year":"1996","journal-title":"Brain Pathol"},{"key":"10.1054\/jocn.2001.1027_RF42","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0736-5748(98)00082-3","article-title":"Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease","volume":"16","author":"Mattson","year":"1998","journal-title":"Int J Devl Neurosci"},{"key":"10.1054\/jocn.2001.1027_RF43","first-page":"17","article-title":"Pathophysiology of the Alzheimer syndrome","author":"Blass","year":"1996"},{"key":"10.1054\/jocn.2001.1027_RF44","first-page":"S7","article-title":"A strategy for identifying immunosuppressive therapies for Alzheimer Disease","volume":"12","author":"Giulian","year":"1998","journal-title":"Alzheimer Disease & Associated Disorders"},{"key":"10.1054\/jocn.2001.1027_RF45","first-page":"282","article-title":"Treatment of advanced Hodgkin's lymphoma: standard and experimental approaches","volume":"36","author":"Engert","year":"1999","journal-title":"Semin Hematol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586801910276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586801910276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T15:54:23Z","timestamp":1554911663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586801910276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0967586801910276"],"URL":"https:\/\/doi.org\/10.1054\/jocn.2001.1027","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}